RE:RE:Clear as mudI think that recent activity should show people that management is out there promoting and moving this company in the right direction. The bashing over investor relations is losing its basis.
The timelines are vague, but atleast we now have some framework of what to expect in 2018 which includes a lot of our unanswered questions regarding functional drink, plant audits, PGX patent and inflammation products. Earnings will continue to be lumpy until that point in which they are selling these new products and are using PGX continuously. However, now we have some "guidance" that we all were waiting to hear.